|
|
|
Translational
Bioinformatics |
| |
AMIA Announces 2008
Summit on Translational Bioinformatics
Other Topics:
Radiotherapy,
Medical Informatics Patents,
Nursing Informatics
PRNewswire-USNewswire
June 21, 2007
Program to address a broad range of topics covering
research-related issues and best practices in bioinformatics and
computational biology
Bethesda, MD -- The American Medical Informatics Association
(AMIA) Board of Directors, in support of its strategic plan, has
approved the development of an annual meeting that will explore
topics related to translational bioinformatics. To reflect the
growth of novel approaches in genomic medicine and biomedicine
at the intersection of clinical care and to better serve its
growing member population of translational scientists, AMIA
recently added translational bioinformatics as one of its three
major strategic domains. This effort, which complements
initiatives in comparative medicine within the scientific
community, will provide a platform to share innovative research
processes that are transforming health care and will strengthen
the clinical research enterprise. |
| |
|
|
| |
"AMIA looks
forward to sponsoring its inaugural research meeting focused
totally on research in Translational Bioinformatics," says Don
E. Detmer, MD, President and CEO. He continues, "AMIA became
aware from conversations with experts in this domain that the
pace of discovery and growth in this emerging field has
outstripped current meeting capabilities. This particular
meeting will help 'personalized' care take on a whole new level
of meaning and benefit the AMIA community and health care as a
whole."
AMIA Board Director, Atul Butte, MD, PhD, Assistant Professor in
Medicine (Medical Informatics) and Pediatrics at the Stanford
University School of Medicine and the Lucile Packard Children's
Hospital, and a board-certified pediatric endocrinologist, will
lead the meeting as the Scientific Program Committee chair. Dr.
Butte's laboratory focuses on solving problems relevant to
genomic medicine by developing new methodologies in
translational bioinformatics. He has authored more than 25
publications in bioinformatics, medical informatics, and
molecular diabetes and has delivered more than 35 presentations
worldwide on bioinformatics, including nine at the National
Institutes of Health or NIH-sponsored meetings.
"Translational Bioinformatics is a new sub-discipline and domain
within biomedical informatics. In 2005, Dr. Elias Zerhouni,
Director of the NIH, wrote that 'At no other time has the need
for a robust, bidirectional information flow between basic and
translational scientists been so necessary.' Clearly evident in
Dr. Zerhouni's quote is the role biomedical informatics needs to
play in facilitating translational medicine," said Butte. "As
translational bioinformatics is now one of AMIA's major domains
of informatics, I am pleased that AMIA will work to build the
first national annual meeting for the presentation and
discussion of research work in this field, and am proud that
AMIA is reaching out to clinical, genomics, and bioinformatics
investigators."
The summit will provide a forum to showcase research-related
issues among the nationwide initiatives on translational
research informatics, such as CTSA, caBIG, NCBC, and others. In
addition, the meeting will bring together leaders in the field
to create a framework for developing, deploying, and assessing
translational bioinformatics initiatives. We anticipate that
non- research issues relating to translational bioinformatics
and clinical research informatics will continue to be part of
the Spring Congress and Annual Symposium.
"With the rapidly emerging and highly visible role of
translational bioinformatics as a central component of our
national biomedical research enterprise, the opportunities for
AMIA and its membership to assume a leadership role in this
critical area are significant," comments Philip R. Payne, MD,
Assistant Professor of Biomedical Informatics, Ohio State
University. "AMIA's recent approval of its third annual meeting,
which will focus on the topic of translational bioinformatics,
is a clear indicator of the Association's strong commitment to
serve as the professional home for practitioners in this domain
and as a premier venue for reporting advances in the state of
translational research."
The summit will take place March 12-15, 2008 at the Hilton San
Francisco in San Francisco, California. A call for participation
and program will be announced in the near future. For more
information about AMIA's translational bioinformatics
activities, visit the AMIA web site at: http://www.amia.org. |
| |
|
|
| |
|
|
